R3 Vascular

Mountain View, CA · Founded 2019 · Privately Held (backing)

Developer of medical metallic stents devices designed to treat peripheral arterial diseases. R3 Vascular is based in Mountain View, CA and was founded in 2019. Its last known valuation is $145 million. It has raised $106 million across 2 recorded rounds; the latest was a $72.5 million later-stage round in Apr 2024.

Last price · $/share
—
Implied valuation
$145.0M
Total raised
$105.6M
Last round
Later Stage VC
Apr 2024
How much has R3 Vascular raised?
$105.6Macross 2 recorded rounds · Aug 2019 – Apr 2024

Most recently, R3 Vascular raised $72.5M in its Later Stage VC (Apr 2024).

Free account
More of R3 Vascular with a free account
  • ·Watch R3 Vascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

R3 Vascular round by round

2 rounds
Apr 2024Later Stage VC$72.5MSEC filing▮
34 investors participated
Aug 2019Debt$2.7MSEC filing▮
23 investors participated

How much has R3 Vascular raised?

R3 Vascular has raised $106 million in total; 2 of its rounds are on record. The largest on record was a $72.5 million later-stage round in Apr 2024.

R3 Vascular has filed 2 Form Ds with the SEC since 2020, most recently in Sep 2024 ($72.5 million sold to 34 investors).

R3 Vascular investors

6 investors are on record for R3 Vascular, including Deerfield Management, 415 Capital, M&L Group and MedFocus. The later-stage round in Apr 2024 drew 34 investors.

For fundraisers
Raising for a company like R3 Vascular?

6 investors have backed R3 Vascular.

See all 6 investors →

Frequently asked about R3 Vascular

How much has R3 Vascular raised?
R3 Vascular has raised $105.6M in total across 2 recorded funding rounds.
When was R3 Vascular's last funding round?
R3 Vascular's most recent recorded round was Later Stage VC in Apr 2024, raising $72.5M.